Authors: Kanesa-thasan, N Sun, W Kim-Ahn, G Van Albert, S Putnak, JR King, A Raengsakulsrach, B Christ-Schmidt, H Gilson, K Zahradnik, JM Vaughn, DW Innis, BL Saluzzo, JF Hoke, CH

Citation: N. Kanesa-thasan et al., Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers, VACCINE, 19(23-24), 2001, pp. 3179-3188

Authors: Kanesa-thasan, N Smucny, JJ Hoke, CH Marks, DH Konishi, E Kurane, I Tang, DB Vaughn, DW Mason, PW Shope, RE

Citation: N. Kanesa-thasan et al., Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus - poxvirus vaccines in vaccinia-nonimmune andvaccinia-immune humans, VACCINE, 19(4-5), 2000, pp. 483-491

Authors: Defraites, RF Gambel, JM Hoke, CH Sanchez, JL Withers, BG Karabatsos, N Shope, RE Tirrell, S Yoshida, I Takagi, M Meschievitz, CK Tsai, TF

Citation: Rf. Defraites et al., Japanese encephalitis vaccine (inactivated, BIKEN) in US soldiers: Immunogenicity and safety of vaccine administered in two dosing regimens, AM J TROP M, 61(2), 1999, pp. 288-293

Authors: Raengsakulrach, B Nisalak, A Gettayacamin, M Thirawuth, V Young, GD Myint, KSA Ferguson, LM Hoke, CH Innis, BL Vaughn, DW

Citation: B. Raengsakulrach et al., An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys, AM J TROP M, 60(3), 1999, pp. 329-337

Authors: Myint, KSA Raengsakulrach, B Young, GD Gettayacamin, M Ferguson, LM Innis, BL Hoke, CH Vaughn, DW

Citation: Ksa. Myint et al., Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus, AM J TROP M, 60(3), 1999, pp. 338-342

Authors: Raengsakulrach, B Nisalak, A Gettayacamin, M Thirawuth, V Young, GD Myint, KSA Ferguson, LM Hoke, CH Innis, BL Vaughn, DW

Citation: B. Raengsakulrach et al., Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEVrecombinant Japanese encephalitis vaccines in rhesus monkeys, AM J TROP M, 60(3), 1999, pp. 343-349